Crea il mio profilo
Accesso pubblico
Visualizza tutto26 articoli
6 articoli
Disponibili
Non disponibili
In base ai mandati di finanziamento
Coautori
- Yoonjeong ChaMITEmail verificata su mit.edu
- Huixiao HongNational Center for Toxicological ResearchEmail verificata su fda.hhs.gov
- Iris GrossmanChief Therapeutics Officer, Eleven TherapeuticsEmail verificata su grossmail.com
- John QuackenbushHarvard T.H. Chan School of Public Health, Channing Division of Network Medicine, and Dana-FarberEmail verificata su hsph.harvard.edu
- Michael HaydenKillam Professor, University of British ColumbiaEmail verificata su cmmt.ubc.ca
- Sarah KolitzImmuneeringEmail verificata su immuneering.com
- Weida TongNCTREmail verificata su FDA.HHS.gov
- Jennifer BeaneBoston University School of MedicineEmail verificata su bu.edu
- Dr. Jermaine RossAlleo LabsEmail verificata su alleolabs.com
- Fadi TowficPrometheus BiosciencesEmail verificata su prometheusbiosciences.com
- John F. Brothers IIBioinformatics ScientistEmail verificata su immuneering.com
- John TedrowSt. Elizabeth's Medical CenterEmail verificata su steward.org
- David A. SchwartzProfessor of Medicine and Immunology, University of ColoradoEmail verificata su ucdenver.edu
- Naftali KaminskiYale School of MedicineEmail verificata su yale.edu
- Frank C SciurbaUniversity of PittsburghEmail verificata su upmc.edu
- Andrew LysaghtImmuneering Corp., Ph.D., Harvard-MIT Joint Division of Health Sciences and TechnologyEmail verificata su alum.mit.edu
- Brian WeinerSeres TherapeuticsEmail verificata su serestherapeutics.com
- Benjamin Haibe-KainsScientist (Principal Investigator), Princess Margaret Cancer Centre, University Health NetworkEmail verificata su uhnresearch.ca
- S PapapetropoulosConsultant, Massachusetts General Hospital, Department of NeurologyEmail verificata su mgh.harvard.edu
- Jason FuntImmuneering CorporationEmail verificata su alum.mit.edu